003017.SZ
大洋生物
SZSE · Basic Materials · C 制造业 · CN
CNY 22.48
+0.27%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
12.3x
Market Cap
CNY 2.27B
MomentumView details →
1D Return
+0.27%
YTD Return
−24.18%
RSI (14)
50.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
12.3x
Market Cap
CNY 2.27B
RSI (14)
50.3
MomentumView details →
1D Return
+0.27%
YTD Return
−24.18%
Similar companies
Latest newsMore news →
Dayang Biology proposed a cash dividend of 3 yuan per 10 shares (tax inclusive) based on 100.8 million shares, with no bonus shares and no capital reserve conversion.12d agoDayang Biology announced its 2026 first-half results: revenue of 559 million yuan, up 11.93% year-on-year; net profit attributable to shareholders of 57.4693 million yuan, up 13.79%; non-GAAP net profit of 53.7404 million yuan, up 14.93%.12d agoNext week, 29 A-share stocks will face share unlockings with a total market value of 27.2 billion yuan, of which Lujiazui has the largest unlocking value at 7.11 billion yuan.28d ago